Clinical Trial Update: A Study of LY2835219 in Japanese Participants With Advanced Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial update of LY2835219 in Japanese participants with advanced cancer has completed recruitment; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Neoplasm Metastasis

Drugs mentioned

• LY2835219 (LY2835219)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Neoplasm Metastasis, Lymphoma | Phase 1 | Status: COMPLETED | Results posted: 2020-08-24